आईएसएसएन:

ऑन्कोलॉजी अनुसंधान और उपचार जर्नल

खुला एक्सेस

हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।

ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं

में अनुक्रमित
  • गूगल ज्ञानी
  • RefSeek
  • हमदर्द विश्वविद्यालय
  • ईबीएससीओ एज़
  • पबलोन्स
  • आईसीएमजेई
इस पृष्ठ को साझा करें

अमूर्त

Beyond Microbiota and Colorectal Cancer: A Critical Review

Vilma Lopes and Gil Faria

Introduction: Cancer is known to be a major cause of morbidity and mortality, making it vital to deepen cancer research. Colorectal cancer is one of the most common cancers and represents the fourth most common cause of death from cancer worldwide. It is a multifactorial disease associated with environmental exposure, DNA mutations, lifestyle, inflammation and recently, microbiota.
Aim: The aim of this review is to discuss the most recent scientific advances in the establishment of a causality link between intestinal microbiota and colorectal cancer, as well as explore the underlying physiopathological mechanisms and theories. It will also be discussed the clinical relevance of the subject.
Results: Most of the studies corroborate a relationship between the microbiota changes and tumorigenesis. However, the existence of a causal relation has not yet been fully clarified. More and more evidence suggests a collective and multifactorial role of the microbiome. Nevertheless, some microorganisms appear to play a prominent role, such as Fusobacterium nucleatum, Escherichia coli and Enteroxigenic Bacteroides fragilis. There has been increasing interest in the clinical potentials of this association, namely by microbiome modulation and creation of potential screening biomarkers.
Conclusions: There is solid evidence of the relationship between microbiome and colorectal cancer. However, it’s not entirely clear yet the causal nature of this relationship, as well as the mechanisms and interactions that characterize it to its fullest extent. The most consistently associated microorganism, and therefore with the greatest clinical potential is Fusobacterium nucleatum. For now, the clinical application of these findings is not a reality, but the potentialities are huge.